GSK PLC

$GSK
Smart money positioned

24 of the Top-200 alpha managers hold $GSK as of the latest 13F snapshot.

13F holders
1,017
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

24 holders · Q1 2026

$GSK is held by 24 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 41.69%, with an average of 2.00% of portfolio. Largest holder: JTC Employer Solutions Trustee Ltd at 41.69%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 1,017 · Source: 13F-HR
01
Second Line Capital, LLC
1.78% of portfolio
58,662,974 sh
02
Banyan Capital Management, Inc.
0.04% of portfolio
38,232,073 sh
03
Citizens Financial Group INC
0.65% of portfolio
34,522,363 sh
04
TB Capital Gestao de Recursos Ltda.
0.20% of portfolio
31,232,236 sh
05
First Financial Bankshares Inc.
1.10% of portfolio
25,204,538 sh
06
Primecap Management CO
0.93% of portfolio
25,130,160 sh
07
Campbell Newman Asset Management Inc.
0.92% of portfolio
11,797,085 sh
08
Bradley & Co. Private Wealth Management, LLC
41.69% of portfolio
9,042,389 sh
09
State Street
0.01% of portfolio
6,252,723 sh
10
Axa S.a.
0.01% of portfolio
5,998,486 sh
See all 1,017 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $GSK in the recent window.

Congress trades · last 90 days

11 disclosures · STOCK Act
House · Michigan · Traded Oct 30
SOLD
$1K–$15K
Nov 21STOCK
House · Michigan · Traded Oct 30
BOUGHT
$1K–$15K
Nov 21STOCK
House · Michigan · Traded Oct 31
SOLD
$1K–$15K
Nov 21STOCK
House · Michigan · Traded Aug 4
BOUGHT
$1K–$15K
Sep 12STOCK
House · Alabama · Traded Jul 28
SOLD
$1K–$15K
Sep 10STOCK
House · Michigan · Traded Jun 17
BOUGHT
$1K–$15K
Aug 13STOCK
House · Michigan · Traded Jun 24
SOLD
$1K–$15K
Aug 13STOCK
House · Arkansas · Traded Apr 21
SOLD
$1K–$15K
May 12STOCK
House · Arkansas · Traded Mar 3
BOUGHT
$1K–$15K
Apr 16STOCK
House · Georgia · Traded Nov 25
BOUGHT
$1K–$15K
Nov 27STOCK
See full $GSK Congress history →

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 04:39 UTC.